Curaleaf Holdings (CURLF) Accumulated Expenses (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Accumulated Expenses of $110.5 million for Q4 2025, up 8.13% year-on-year from $102.2 million in Q4 2024, and up 8.13% on a QoQ basis from $102.2 million in Q4 2024.

Curaleaf Holdings (CURLF) Accumulated Expenses (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Accumulated Expenses for 7 consecutive years, with $110.5 million the latest figure, recorded in Q4 2025.

  • Quarterly Accumulated Expenses rose 8.13% year-over-year to $110.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $110.5 million (up 8.13% YoY) and the FY2025 annual result came in at $110.5 million, up 8.13% from the prior year.
  • Accumulated Expenses improved to $110.5 million in Q4 2025 per CURLF's latest filing, from $102.2 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for CURLF reached as high as $95.8 billion in Q1 2022 and fell as low as $54.4 million in Q1 2021.
  • A 5-year average of $6.5 billion and a median of $101.3 million in 2023 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses soared 176163.61% — and 2023, when it decreased 1.94%.
  • Year by year, Accumulated Expenses stood at $87.0 million in 2021, then increased by 18.79% to $103.3 million in 2022, then decreased by 1.94% to $101.3 million in 2023, then advanced by 0.87% to $102.2 million in 2024, then climbed by 8.13% to $110.5 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $110.5 million, $102.2 million, and $115.6 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 110.49 Mn
Dec 31, 2024 102.19 Mn
Sep 30, 2024 115.61 Mn
Jun 30, 2024 107.74 Mn
Dec 31, 2023 101.31 Mn
Sep 30, 2023 100.97 Mn
Jun 30, 2023 105.46 Mn
Dec 31, 2022 103.31 Mn
Sep 30, 2022 95.34 Mn
Jun 30, 2022 89.46 Mn
Mar 31, 2022 95.83 Bn
Dec 31, 2021 86.97 Mn
Sep 30, 2021 80.65 Mn
Jun 30, 2021 59.67 Mn
Mar 31, 2021 54.37 Mn
Dec 31, 2020 57.48 Mn
Sep 30, 2020 44.81 Mn
Dec 31, 2019 18.02 Mn